IDEAYA Biosciences (NASDAQ:IDYA) Price Target Raised to $36.00
IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective boosted by Royal Bank of Canada from $32.00 to $36.00 in a report published on Tuesday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other equities analysts have also commented on the stock. SVB Leerink assumed coverage on shares […]
More Stories
Vipshop Holdings Limited (NYSE:VIPS) Receives $17.50 Average PT from Analysts
Shares of Vipshop Holdings Limited (NYSE:VIPS – Get Free Report) have earned a consensus rating of “Hold” from the seven...
Crown Castle (NYSE:CCI) and CubeSmart (NYSE:CUBE) Head to Head Review
CubeSmart (NYSE:CUBE – Get Free Report) and Crown Castle (NYSE:CCI – Get Free Report) are both finance companies, but which...
Contrasting Wynn Macau (OTCMKTS:WYNMY) and Civeo (NYSE:CVEO)
Civeo (NYSE:CVEO – Get Free Report) and Wynn Macau (OTCMKTS:WYNMY – Get Free Report) are both consumer discretionary companies, but...
Analysts Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) PT at $31.67
Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have earned a consensus rating of “Buy” from the seven...
Reviewing HUYA (NYSE:HUYA) & Nexxen International (NASDAQ:NEXN)
HUYA (NYSE:HUYA – Get Free Report) and Nexxen International (NASDAQ:NEXN – Get Free Report) are both small-cap computer and technology...
Brokerages Set indie Semiconductor, Inc. (NASDAQ:INDI) Price Target at $8.92
indie Semiconductor, Inc. (NASDAQ:INDI – Get Free Report) has been assigned an average rating of “Buy” from the six research...